# Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis

> **NCT00216177** · PHASE4 · UNKNOWN · sponsor: **Hvidovre University Hospital** · enrollment: 112 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Infliximab
- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT00216177
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-06
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2009-08-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216177, "Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00216177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*